Lake Resources raises $4.5 million in oversubscribed placement

|

Published 22-MAR-2018 12:00 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Lithium exploration company, Lake Resources N.L. (ASX:LKE) today announced it has secured commitments to raise A$4.5 million in an oversubscribed private placement to sophisticated and professional investors.

The original offer was increased from $4 million due to significant demand from current shareholders, with the upsized $4.5 million raise to be completed by Monday 26 March 2018.

The funds will be raised by way of the issue of 33,333,335 new ordinary LKE shares at $0.135 per share with an attached 1-for-2 option exercisable at $0.20 on or before 15 December 2018.

LKE will be seeking quotation of the attaching options subject to meeting the listing requirements under the ASX Listing Rules. Patersons Securities Limited and Hunter Capital Advisors Pty Ltd were joint lead managers of the capital raise.

The funds will be used by the small-cap to undertake further exploration at its Olaroz, Cauchari and Paso Lithium Brine Projects, as well as providing cash flow for ongoing drilling and initial scoping studies at the Kachi Lithium Brine Project. A percentage of the funds will be put towards repaying outstanding notes and general working capital.

LKE Managing Director Steve Promnitz commented on today’s announcement: “Lake is grateful for the overwhelming interest to support exploration over the Olaroz and Cauchari areas as they are immediately adjacent to high grade lithium production or drill holes with high grades and flow rates.”

It should be noted though, that this is an early stage play and investors should seek professional financial advice if considering this stock for their portfolio.

The company’s flagship brine projects cover more than 170,000 hectares and have similar settings to some other major world-class brine projects currently being developed in Argentina’s Lithium Triangle.

Its Olaroz/ Cauchari projects are adjacent to Orocobre’s (ASX:ORE) Olaroz lithium production project and SQM/Lithium Americas Cauchari development project.

LKE is currently drilling at the Kachi Lithium Brine Project, nearby Albemarle’s Antofalla Project, and expect to release results from April/May onwards.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X